Recent Progress of Ultrasound Therapy for Antibacterial Applications
Small · 2026-11 · 22 (61)
DOI: 10.1002/smll.75894 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 23.09.2026. Verfasst von Zhenxing Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory for Processing and Application of Catalytic Materials, Hubei Provincial Engineering Research Center of High Purity Raw Material …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Ultrasonic Therapy, Bacterial Infections. Die Arbeit nennt 209 Literaturangaben. Gefördert von: high-level cultivation project of Huanggang Normal University, Doctoral Foundation of Huanggang Normal University, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Bacterial infections, especially deep‐seated tissue infections caused by drug‐resistant bacteria and the formation of biofilms, have become a major challenge in modern medicine. Traditional antibiotic treatment faces problems such as decreased efficiency, side effects, and further induction of drug resistance. Therefore, it is crucial to explore and develop new antibacterial methods that do not rely on traditional antibiotics. Ultrasound antibacterial therapy, as a non‐invasive, highly tissue‐penetrating and antibiotic‐free novel treatment method, is gradually becoming a powerful weapon for solving multidrug‐resistant (MDR) bacterial infections. Despite the significant advantages of ultrasound therapy in addressing MDR bacterial infections, its clinical translation for antimicrobial applications still faces numerous challenges. Starting from the potential mechanisms of ultrasound effects, this review discusses the specific strategies for optimizing ultrasound response performance. In addition, we also summarize the latest research progress on antibacterial mechanisms and applications of ultrasound therapy. Ultrasound therapy can be combined with other therapies such as phototherapy, chemodynamic therapy, gas therapy, ion therapy, and antimicrobial peptides for achieving improved antibacterial performance. Finally, the current challenges in clinical translation and future development directions of ultrasound antibacterial therapy were discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory for Processing and Application of Catalytic Materials, Hubei Provincial Engineering Research Center of High Purity Raw Material Processing Technology of Electronic Materials, College of Chemistry an…
- Ministry-of-Education Key Laboratory for the Green Preparation and Application of Functional Materials, School of Materials Science and Engineering, Hubei University, Wuhan, China.
- School of Health Science & Biomedical Engineering, Hebei University of Technology, Tianjin, China.
- State Key Laboratory of Advanced Waterproof Materials, School of Materials Science and Engineering, Peking University, Beijing, China.
ORCID-Profile: Xiangmei Liu, Shuilin Wu
Förderung
- high-level cultivation project of Huanggang Normal University
- Doctoral Foundation of Huanggang Normal University
- Natural Science Foundation of Hubei Province
- First Batch of Joint Funding (Special Support) from the China Postdoctoral Science Foundation and Hubei Province
- China Postdoctoral Science Foundation
- China National Funds for Distinguished Young Scientists
- Yanzhao Young Scientist Project
- Beijing Natural Science Foundation
Zitieren
APA
Yang, Z., Chen, C., Liu, X., & Wu, S. (2026). Recent Progress of Ultrasound Therapy for Antibacterial Applications. Small, 22(61). https://doi.org/10.1002/smll.75894
Vancouver
Yang Z, Chen C, Liu X, Wu S. Recent Progress of Ultrasound Therapy for Antibacterial Applications. Small. 2026;22(61). doi:10.1002/smll.75894
BibTeX
@article{Yang2026,
author = {Yang, Zhenxing and Chen, Cuihong and Liu, Xiangmei and Wu, Shuilin},
title = {Recent Progress of Ultrasound Therapy for Antibacterial Applications},
journal = {Small},
year = {2026},
volume = {22},
number = {61},
doi = {10.1002/smll.75894}
}
EUVIMED